HLTA4H/hLTA4S-IN-1
HLTA4H/hLTA4S-IN-1 is a possible dual inhibitor that has the activity of inhibiting both human leukotriene hydrolase (hLTA4H) and human leukotriene C4 synthase (hLTC4S) . hLTA4H/hLTA4S-IN-1 was identified by computer-assisted methods and is able to effectively interfere with the leukotriene biosynthesis pathway in cells. hLTA4H/hLTA4S-IN-1 can be used to study inflammatory responses[1].
Product Specifications
CAS Number
128253-12-3
UNSPSC
12352005
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/hlta4h-hlta4s-in-1.html
Smiles
O=C(C(C1CCCC1)C2=CC=C(C=C2)OCC3=NC4=C(C=C3)C=CC=C4)O
Molecular Formula
C23H23NO3
Molecular Weight
361.43
References & Citations
[1]Molecular docking and pharmacophore filtering in the discovery of dual-inhibitors for human leukotriene A4 hydrolase and leukotriene C4 synthase
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
NRF1 (NRF1/2609), CF568 conjugate, 0.1mg/mL
Adipophilin / Perilipin-2 (Marker of Obesity) (ADFP/1366), CF568 conjugate, 0.1mg/mL
